We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$368M
2
CSCO icon
Cisco
CSCO
+$131M
3
WMT icon
Walmart Inc
WMT
+$109M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$93.1M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$87.2M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$124M
2
PX
Praxair Inc
PX
+$110M
3
KHC icon
Kraft Heinz
KHC
+$86.3M
4
XNTK icon
State Street SPDR NYSE Technology ETF
XNTK
+$67.4M
5
PSA icon
Public Storage
PSA
+$56.7M

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAC
3401
DELISTED
AAC Holdings
AAC
$23K ﹤0.01%
16,080
-900
-5% -$3.61K
MXWL
3402
DELISTED
Maxwell Technologies Inc
MXWL
$23K ﹤0.01%
11,160
-1,200
-10% -$3.25K
F icon
3403
PUT
Ford
F
$55.8B
$22K ﹤0.01%
+44,000
New +$392K
SDR
3404
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$22K ﹤0.01%
25,583
+3,250
+15% +$3.54K
TT icon
3405
CALL
Trane Technologies
TT
$105B
$21K ﹤0.01%
27,600
+16,300
+144% +$1.6M
PLM
3406
DELISTED
PolyMet Mining Corp.
PLM
$21K ﹤0.01%
2,640
+1,190
+82% +$10.4K
WHWK
3407
Whitehawk Therapeutics
WHWK
$259M
$20K ﹤0.01%
800
– –
AMGN icon
3408
CALL
Amgen
AMGN
$226B
$19K ﹤0.01%
31,200
-800
-3% -$156K
TGB
3409
Trekor Metals
TGB
$3.21B
$19K ﹤0.01%
+40,700
New +$26.2K
VIVS
3410
VivoSim Labs
VIVS
$1.27M
$19K ﹤0.01%
81
-54
-40% -$13.6K
PER
3411
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$19K ﹤0.01%
10,048
-1,999
-17% -$4.63K
ELDN icon
3412
Eledon Pharmaceuticals
ELDN
$284M
$18K ﹤0.01%
608
– –
GEN icon
3413
CALL
Gen Digital
GEN
$17.5B
$18K ﹤0.01%
78,700
+9,300
+13% +$192K
NOVN
3414
DELISTED
Novan, Inc. Common Stock
NOVN
$18K ﹤0.01%
+2,150
New +$43.9K
ECT
3415
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$18K ﹤0.01%
12,300
+2,000
+19% +$3.61K
BLNK icon
3416
Blink Charging
BLNK
$86M
$17K ﹤0.01%
+10,100
New +$22K
CANF
3417
Can-Fite BioPharma American Depositary Shares
CANF
$6.88M
$17K ﹤0.01%
5
– –
NMM icon
3418
Navios Maritime Partners
NMM
$2.24B
$17K ﹤0.01%
1,324
+100
+8% +$2.05K
REFR icon
3419
Research Frontiers
REFR
$17.1M
$17K ﹤0.01%
11,000
– –
CTHR
3420
DELISTED
Charles & Colvard Ltd
CTHR
$17K ﹤0.01%
2,050
-1,170
-36% -$10.6K
ATHX
3421
DELISTED
Athersys, Inc. Common Stock
ATHX
$16K ﹤0.01%
445
+8
+2% +$382
IDXG
3422
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$16K ﹤0.01%
2,000
– –
GG
3423
CALL
DELISTED
Goldcorp Inc
GG
$16K ﹤0.01%
60,800
+4,200
+7% +$40.7K
PLUG icon
3424
Plug Power
PLUG
$2.94B
$15K ﹤0.01%
12,426
-40
-0.3% -$68
XBI icon
3425
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$15K ﹤0.01%
42,000
+900
+2% +$72.5K
135 136
137
138 139

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.